Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01429220 · ClinicalTrials.gov registry record
Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 9
- Enrollment target
NCT01429220: Completed study, sponsored by Great Lakes NeuroTechnologies.
NCT01429220 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01429220 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the utility of a portable motion sensor-based system designed to assist with deep brain stimulation (DBS) programming sessions for Parkinson's disease patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-08 |
What the finished NCT01429220 record still lists
NCT01429220 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01429220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01429220 about?
NCT01429220 is a clinical study titled "Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming". The purpose of this study is to evaluate the utility of a portable motion sensor-based system designed to assist with deep brain stimulation (DBS) programming sessions for Parkinson's disease patients.
What is the current status of trial NCT01429220?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2011-08.
Who is sponsoring clinical trial NCT01429220?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia